SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Analyst: 3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven
Deals
Turns Out Gilead May Have Wanted Tobira Too
October 19, 2016
 · 
3 min read
Deals
Gilead: Expect Focus On Products, Not Acquisitions
October 17, 2016
 · 
1 min read
Gilead Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma
Deals
Survey Says... Gilead Should Buy This Company
October 11, 2016
 · 
2 min read
Drug Development
4 Small Biotechs That Could Give Gilead, Merck & Co. Pfizer Some Competition With NASH
October 7, 2016
 · 
1 min read
Gilead Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency
Deals
A Look at Gilead’s Price Tag and Who May be Interested in Buying
October 5, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Gilead Might Avoid Fighting Celgene, But Allergan, Intercept Pharma and Novartis AG Await
October 3, 2016
 · 
2 min read
Gilead Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma
Deals
Gilead Can’t Buy Belgium’s Galapagos—Yet
September 28, 2016
 · 
3 min read
Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech
Deals
Speculation Mounts Over an Allergan-Gilead Mega Deal
September 23, 2016
 · 
3 min read
Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech
Drug Development
This Biotech Has the Upper Hand Over Allergan and Gilead in the Heated Nash Battle
September 23, 2016
 · 
2 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Biotech Bay
Gilead’s Plan to Dominate the Hepatitis C Market
June 27, 2016
 · 
1 min read
Biotech Bay
European Commission (EC) Grants Marketing Authorization For Gilead’s Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For The Treatment Of HIV
June 23, 2016
 · 
5 min read
Policy
What Gilead and Martin Shkreli Have in Common
June 23, 2016
 · 
1 min read
Drug Development
Two Upstarts that Could Dislodge Gilead’s Hold on the Hepatitis C Market
June 22, 2016
 · 
1 min read
Drug Development
Gilead Presents Preliminary Data On Bictegravir, An Investigational Integrase Strand Transfer Inhibitor For The Treatment Of HIV
June 20, 2016
 · 
4 min read
Biotech Bay
Gilead To Present At The 36th Annual William Blair Growth Stock Conference On Tuesday, June 14
June 14, 2016
 · 
1 min read
Biotech Bay
Gilead To Present At The Jefferies 2016 Healthcare Conference On Friday, June 10
June 10, 2016
 · 
1 min read
Biotech Bay
Gilead To Present At The Goldman, Sachs & Co. 37th Annual Global Healthcare Conference On Wednesday, June 8
June 8, 2016
 · 
1 min read
Business
New Gilead CEO’s Game Plan to Maintain HCV Dominance
June 8, 2016
 · 
1 min read
Policy
Lawsuit Claims Gilead Could Have Created Safer HIV Drug Sooner But Didn’t Due to Profits
May 31, 2016
 · 
1 min read
Load More